Hall Kiriluk Sarah, Johnson Anne Holly, Kaplan Jonathan R M, Vulcano Ettore, Lewis Thomas, Lam Peter, Schipper Oliver, Jackson J Benjamin, Gonzalez Tyler A
University of South Carolina, School of Medicine, Columbia, SC, USA.
Hospital for Special Surgeries, New York, NY, USA.
Foot Ankle Int. 2025 Aug;46(8):887-894. doi: 10.1177/10711007251341890. Epub 2025 Jun 26.
The percutaneous dorsal closing wedge calcaneal Zadek osteotomy (ZO) is an effective treatment for patients with insertional Achilles tendinopathy (IAT), although consensus is lacking on ideal patient selection. Tourné et al proposed that a preoperative calcaneal X/Y ratio <2.5 defines surgical candidacy, but this criterion remains controversial. This study evaluated whether patients with IAT benefit from percutaneous ZO regardless of preoperative X/Y ratio.
A retrospective comparative study of 27 patients undergoing percutaneous ZO was performed. Patients were stratified into 2 cohorts based on preoperative X/Y ratio (<2.5 vs ≥2.5). Primary outcomes were PROMIS scores for pain, function, and mobility at 3, 6, and 12 months. Secondary outcomes included complication rates and radiographic parameters. Minimal clinically important differences were used to assess clinical significance.
Between May 2022 and May 2024, 27 cases were included in the current analyses. Seventeen cases had an X/Y <2.5; 10 had an X/Y ≥2.5. Both cohorts demonstrated significant improvement in PROMIS pain, function, mobility scores ( < .05). Patients with X/Y ≥2.5 demonstrated statistically greater improvement in pain scores than patients with X/Y <2.5 ( = .049) at 1-year follow-up. Ninety-eight percent of patients were satisfied following ZO intervention.
Percutaneous ZO demonstrated meaningful improvement in patients' function, pain, and mobility regardless of preoperative X/Y ratio. These findings challenge the use of the <2.5 X/Y threshold as a strict selection criterion. Percutaneous ZO may be a viable option for a broader population of IAT patients than previously considered.
经皮跟骨背侧闭合楔形Zadek截骨术(ZO)是治疗跟腱附着点病(IAT)患者的有效方法,尽管在理想的患者选择上缺乏共识。图尔内等人提出,术前跟骨X/Y比值<2.5可确定手术候选资格,但该标准仍存在争议。本研究评估了无论术前X/Y比值如何,IAT患者是否能从经皮ZO手术中获益。
对27例行经皮ZO手术的患者进行回顾性比较研究。根据术前X/Y比值(<2.5 vs≥2.5)将患者分为两组。主要结局指标为术后3个月、6个月和12个月时疼痛、功能和活动能力的患者报告结果测量信息系统(PROMIS)评分。次要结局指标包括并发症发生率和影像学参数。采用最小临床重要差异评估临床意义。
在2022年5月至2024年5月期间,本分析纳入了27例病例。17例X/Y<2.5;10例X/Y≥2.5。两组患者的PROMIS疼痛、功能、活动能力评分均有显著改善(P<0.05)。在1年随访时,X/Y≥2.5组患者的疼痛评分改善在统计学上高于X/Y<2.5组患者(P = 0.049)。98%的患者在ZO手术后表示满意。
无论术前X/Y比值如何,经皮ZO手术均能显著改善患者的功能、疼痛和活动能力。这些发现对将X/Y<2.5作为严格选择标准提出了挑战。对于IAT患者,经皮ZO手术可能是一个比之前认为的更广泛人群的可行选择。